Medication overuse headache

Australian Prescriber

Volumn 28, Issue 6, 2005, Pages 143-145

  Williams, David ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Analgesia; Migraine

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ERGOTAMINE; OPIATE; SUMATRIPTAN; TRIPTAN DERIVATIVE;

DIAGNOSTIC TEST; ECONOMIC ASPECT; HEADACHE; HUMAN; MIGRAINE; POPULATION RESEARCH; SHORT SURVEY; SOCIAL PSYCHOLOGY;

EID: 30644460278     PISSN: 03128008     EISSN: 03128008     Source Type: Journal    
DOI: 10.18773/austprescr.2005.109     Document Type: Short Survey

References (6)

1. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurology 2004;3:475-83.
2. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, et al, for the International Headache Society. The international classification of headache disorders. 2nd ed. Cephalalgia 2004;24(Suppl 1):1-160.
3. Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004;62:788-90.
4. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002;59:1011-4.
5. Williams DR, Stark RJ. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia 2003;23:963-71.
6. Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 2000;20:107-13.